Gostanian Richard

Related Filers (1)

Ownership (13)

5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
5
Monday, 4/2/2018
Immune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
Show More